FR2012421A1 - - Google Patents

Info

Publication number
FR2012421A1
FR2012421A1 FR6922940A FR6922940A FR2012421A1 FR 2012421 A1 FR2012421 A1 FR 2012421A1 FR 6922940 A FR6922940 A FR 6922940A FR 6922940 A FR6922940 A FR 6922940A FR 2012421 A1 FR2012421 A1 FR 2012421A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6922940A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella AG
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG, Cassella Farbwerke Mainkur AG filed Critical Cassella AG
Publication of FR2012421A1 publication Critical patent/FR2012421A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR6922940A 1968-07-05 1969-07-07 Withdrawn FR2012421A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1010668A CH514611A (en) 1968-07-05 1968-07-05 Process for the preparation of derivatives of 2-oxo-1,2-dihydro-quinoline

Publications (1)

Publication Number Publication Date
FR2012421A1 true FR2012421A1 (en) 1970-03-20

Family

ID=4359412

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6922940A Withdrawn FR2012421A1 (en) 1968-07-05 1969-07-07

Country Status (6)

Country Link
BE (1) BE735694A (en)
CH (3) CH514611A (en)
DE (1) DE1932384A1 (en)
FR (1) FR2012421A1 (en)
GB (1) GB1212174A (en)
NL (1) NL6909748A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103590A (en) * 1972-04-13 1973-12-25
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
EP0005828B1 (en) * 1978-06-06 1981-03-11 Hoechst Aktiengesellschaft New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation
DE2827566A1 (en) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-DIHYDRO-CHINOLIN-2-ON DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB2379284A (en) 2001-09-01 2003-03-05 Zarlink Semiconductor Ltd Multiple level photolithography
GB2379796A (en) 2001-09-14 2003-03-19 Zarlink Semiconductor Ltd A method of forming a low resistance contact
EP3133066A1 (en) * 2015-08-21 2017-02-22 Merck Patent GmbH Hydrophilic compounds for optically active devices
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE723211A (en) * 1967-11-03 1969-04-30

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE723211A (en) * 1967-11-03 1969-04-30

Also Published As

Publication number Publication date
BE735694A (en) 1970-01-05
CH534687A (en) 1973-03-15
CH523899A (en) 1972-06-15
DE1932384A1 (en) 1970-01-15
CH514611A (en) 1971-10-31
GB1212174A (en) 1970-11-11
NL6909748A (en) 1970-01-07

Similar Documents

Publication Publication Date Title
AU1946070A (en)
AU5506869A (en)
AU2374870A (en)
AU5184069A (en)
FR2012421A1 (en)
AU6168869A (en)
AU6171569A (en)
AU429879B2 (en)
AU416157B2 (en)
AU2581067A (en)
AU4811568A (en)
AU421558B1 (en)
AR203075Q (en)
AU4744468A (en)
AU3789668A (en)
AU2580267A (en)
AU3224368A (en)
BE724093A (en)
AU479894A (en)
BE726631A (en)
AU3083868A (en)
BE726294A (en)
BE726284A (en)
BE709446A (en)
BE724085A (en)

Legal Events

Date Code Title Description
ST Notification of lapse